Since Trump began his second term last year, the U.S. government has invested in nearly a dozen publicly traded companies.

As US regulatory agencies move toward phasing out animal testing, efforts to downplay the mistreatment of laboratory animals reflect a disconnect from current ethical and scientific standards.